Purevax Feline Rabies - 1901.R1

Verify with FDA CVM →

167 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
167
Total Reports
26
Deaths Reported
1560.0%
Death Rate

Active Ingredients

Purevax Feline Rabies - 1901.R1

Administration Routes

SubcutaneousUnknown

Species Affected

Cat 165
Dog 2

Most Affected Breeds

Domestic Shorthair 109
Domestic Longhair 13
Domestic Mediumhair 11
Siamese 7
Cat (other) 5
Cat (unknown) 4
Burmese 2
Maine Coon 2
Bengal 2
Himalayan 2

Most Reported Reactions

Vomiting 48
Lethargy (see also Central nervous system depression in 'Neurological') 38
Lethargy (see also Central nervous system depression in Neurological) 29
Anorexia 27
Not eating 27
Fever 23
Weight loss 17
Other abnormal test result NOS 14
Death 14
Hiding 13
Elevated total bilirubin 13
Diarrhoea 12

Outcome Breakdown

Outcome Unknown
75 (44.9%)
Recovered/Normal
47 (28.1%)
Ongoing
19 (11.4%)
Died
14 (8.4%)
Euthanized
12 (7.2%)

Data Summary

Metric Value
Total adverse event reports 167
Reports involving death 26
Case-fatality rate (reported events) 1560.0%
Distinct species in reports 2
Distinct breeds in reports 18
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Purevax Feline Rabies - 1901.R1 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 167 adverse event reports referencing Purevax Feline Rabies - 1901.R1, including 26 reports in which the animal died — a 1560.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Purevax Feline Rabies - 1901.R1. Reported administration routes include Subcutaneous, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Purevax Feline Rabies - 1901.R1 reports are Cat (165 reports), Dog (2 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (109), Domestic Longhair (13), Domestic Mediumhair (11) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Purevax Feline Rabies - 1901.R1 are Vomiting (48), Lethargy (see also Central nervous system depression in 'Neurological') (38), Lethargy (see also Central nervous system depression in Neurological) (29), Anorexia (27). Of the 167 reports with a coded outcome, Outcome Unknown is the leading category at 44.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Purevax Feline Rabies - 1901.R1.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial